Theralase Technologies Inc
XTSX:TLT
Theralase Technologies Inc
EPS (Diluted)
Theralase Technologies Inc
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Theralase Technologies Inc
XTSX:TLT
|
EPS (Diluted)
CA$0
|
CAGR 3-Years
0%
|
CAGR 5-Years
17%
|
CAGR 10-Years
0%
|
|
|
Titan Medical Inc
TSX:TMD
|
EPS (Diluted)
$0
|
CAGR 3-Years
53%
|
CAGR 5-Years
54%
|
CAGR 10-Years
37%
|
|
|
Profound Medical Corp
TSX:PRN
|
EPS (Diluted)
-$1
|
CAGR 3-Years
9%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
Nanalysis Scientific Corp
XTSX:NSCI
|
EPS (Diluted)
CA$0
|
CAGR 3-Years
-39%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
MedMira Inc
XTSX:MIR
|
EPS (Diluted)
CA$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
O
|
Ondine Biomedical Inc
LSE:OBI
|
EPS (Diluted)
CA$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Theralase Technologies Inc
Glance View
Theralase Technologies, Inc. engages in the design, development, and manufacture of patented laser technology platforms used in bio-stimulative and bio-destructive clinical applications in patients. The company is headquartered in East York, Ontario. The company went IPO on 2004-11-02. The firm is engaged in the research and development of light activated compounds and their associated drug formulations with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. The firm operates through two divisions, The Anti-Cancer Therapy (ACT) and The Cool Laser Therapy (CLT). ACT division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. CLT division designs, develops, manufactures and markets patented, and its laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerves, muscle and joint conditions. The firm develops products both internally and using the assistance of external resources.
See Also
What is Theralase Technologies Inc's EPS (Diluted)?
EPS (Diluted)
-0
CAD
Based on the financial report for Dec 31, 2024, Theralase Technologies Inc's EPS (Diluted) amounts to -0 CAD.
What is Theralase Technologies Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
0%
Over the last year, the EPS (Diluted) growth was 0%.
You don't have any saved screeners yet